Corrigendum: ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling Pathway

Frontiers in Pharmacology

Jian-Yong Zhu¹  Chun-Yan Zhang¹  Su-Juan Wang²  Yi-ping Jiang³  Ming-Hua Ma⁴  Li-Jun Zhang⁵  Hong Zhang⁵  Khalid Rahman⁶  Xiao-Qin Li⁷  Xin Luan⁸  Yu-Li Shen⁸ 

[1] Central Laboratory, Seventh People’s Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China;Department of Drug Preparation, Hospital of TCM and Hui Nationality Medicine, Ningxia Medical University, Wuzhong, China;Department of Pharmacognosy, School of Pharmacy, Second Military Medical University, Shanghai, China;Department of Pharmacy, Yangpu Hospital, Tongji University School of Medicine, Shanghai, China;Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China;School of Pharmacy and Biomolecular Sciences, Faculty of Science, Liverpool John Moores University, Liverpool, United Kingdom;School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China;Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China;

关键词: erhuang formula;    renal fibrosis;    diabetic nephropathy;    mechanism;    JAK/STAT3;   

DOI  :  10.3389/fphar.2021.789192

来源: DOAJ

【 授权许可】

Unknown